ArticleCureus2024

Possibility of Human Epidermal Growth Factor Receptor 2 Expression as a Treatment Selection Indicator in Early Triple-Negative Breast Cancer.

Namiko Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.